NCT04245241View on ClinicalTrials.gov

Effects of High-Flow Nasal Cannula Therapy Assessed by Electrical Impedance Tomography

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

July 1, 2019

Study Completion Date

November 1, 2019

Conditions
High-flow Nasal CannulaElectrical Impedance Tomography
Interventions
OTHER

High-flow nasal cannula (HFNC)

24 patients who receiving HFNC within 24 hours after extubation were prospectively enrolled in this study. EIT was used to monitor regional lung ventilation distributions at baseline (conventional oxygen therapy) and three flow rate levels of HFNC therapy (20, 40 and 60 L/min).

Trial Locations (1)

100730

Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences,, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT04245241 - Effects of High-Flow Nasal Cannula Therapy Assessed by Electrical Impedance Tomography | Biotech Hunter | Biotech Hunter